Evaluation of the Effectiveness of a Product Containing Topical Hydrocortisone in the Treatment of Seborrheic Dermatitis of the Face (13244/2009)

Allergisa

Status: Unknown

Conditions: Seborrheic Dermatitis

Study type: Observational

Funder types: Industry

Identifiers

NCT01024374

All-E-M-13244-01/02-10-09

Details and patient eligibility

About

Clinical single-blind randomized comparison with the overall objective of evaluating the clinical efficacy of the products Nutracort lotion and Nutracort cream in the treatment of seborrheic dermatitis on the face.

Will be held clinical and perceived efficacy assessment and instrumental measurements. Each product will be applied at half face for 7 consecutive days and all applications will be monitored in the research site. 60 volunteers will be recruited.

Evaluations will be held at the following times: T0 - before the initial application of the product; T1 - 24 hours after starting treatment, T2 - 48 hours after starting treatment, T3 - 72 hours after initiation of treatment, T4 - 96 hours after the start treatment, T7 - 7 days after initiation of treatment.

Enrollment: 60 estimated patients

Sex: All

Ages: 18 to 60 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy subjects
• Subjects with seborrheic dermatitis on both sides of the face
• both sexes
• aged 18 to 60 years
• skin types I through IV.

Exclusion criteria

• pregnancy / lactation
• skin condition in the area of application of the product
• diabetes
• immune insufficiency
• subjects that are using systemic corticoids
• subjects that are using immunosuppressors
• skin diseases: vitiligo, psoriasis, lupus, atopic dermatitis
• history of reaction to the product category
• other diseases or medications that might interfere directly in the study or endanger the health of the subject